The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.

1 Dichloroacetate (DCA) is a promising treatment for lactic acidosis complicating severe malaria. The pharmacokinetics, pharmacodynamics and toxicity of dichloroacetate were evaluated in 11 patients with severe malaria, and their lactate responses compared with nine control patients in an open-label...

Full description

Bibliographic Details
Main Authors: Krishna, S, Supanaranond, W, Pukrittayakamee, S, Kuile, F, Ruprah, M, White, N
Format: Journal article
Language:English
Published: 1996
_version_ 1797097859017867264
author Krishna, S
Supanaranond, W
Pukrittayakamee, S
Kuile, F
Ruprah, M
White, N
author_facet Krishna, S
Supanaranond, W
Pukrittayakamee, S
Kuile, F
Ruprah, M
White, N
author_sort Krishna, S
collection OXFORD
description 1 Dichloroacetate (DCA) is a promising treatment for lactic acidosis complicating severe malaria. The pharmacokinetics, pharmacodynamics and toxicity of dichloroacetate were evaluated in 11 patients with severe malaria, and their lactate responses compared with nine control patients in an open-label prospective study. 2 Intravenous DCA (46 mg kg-1 infused in 30 min) or saline placebo was given on admission to the study, and 12 h later, as an adjunct to standard quinine treatment. 3 An open one-compartment model with the following parameters described the pharmacokinetics of DCA after one dose (mean [s.d.]): V = 0.44(0.2) 1 kg-1; CL = 0.13 [0.027] 1 h-1 kg-1; Cmax = 106[28] mg1-1; t1/2 = 3.4(2.2) h. After two doses of DCA (n = 9) the pharmacokinetic parameters were similar to those after the first dose. 4 DCA decreased venous plasma lactate concentrations by 42% of baseline values 8 h after admission, normalized arterial pH from a mean(s.d.) of 7.367(0.063) to 7.39(0.1), and decreased the calculated base deficit from 9.2(7.3) mEq 1-1 to 6.4(10.4) mEq 1-1. In control patients lactate concentrations fell by approximately 14% of baseline concentrations (P < 0.02 compared with DCA recipients). Venous lactate concentrations fell a further 16% from baseline values after the second dose of DCA but this change was not significantly different from controls. There was no electrocardiographic or other evidence of toxicity associated with DCA. 5 These data suggest that a single intravenous infusion of DCA rapidly reduces hyperlactataemia in patients severely ill with malaria, and that DCA should be evaluated further as an adjunct to conventional antimalarial and supportive measures for such patients with lactic acidosis.
first_indexed 2024-03-07T05:01:18Z
format Journal article
id oxford-uuid:d85e70ca-434d-497d-9aa2-5091a2357ae1
institution University of Oxford
language English
last_indexed 2024-03-07T05:01:18Z
publishDate 1996
record_format dspace
spelling oxford-uuid:d85e70ca-434d-497d-9aa2-5091a2357ae12022-03-27T08:48:10ZThe disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d85e70ca-434d-497d-9aa2-5091a2357ae1EnglishSymplectic Elements at Oxford1996Krishna, SSupanaranond, WPukrittayakamee, SKuile, FRuprah, MWhite, N1 Dichloroacetate (DCA) is a promising treatment for lactic acidosis complicating severe malaria. The pharmacokinetics, pharmacodynamics and toxicity of dichloroacetate were evaluated in 11 patients with severe malaria, and their lactate responses compared with nine control patients in an open-label prospective study. 2 Intravenous DCA (46 mg kg-1 infused in 30 min) or saline placebo was given on admission to the study, and 12 h later, as an adjunct to standard quinine treatment. 3 An open one-compartment model with the following parameters described the pharmacokinetics of DCA after one dose (mean [s.d.]): V = 0.44(0.2) 1 kg-1; CL = 0.13 [0.027] 1 h-1 kg-1; Cmax = 106[28] mg1-1; t1/2 = 3.4(2.2) h. After two doses of DCA (n = 9) the pharmacokinetic parameters were similar to those after the first dose. 4 DCA decreased venous plasma lactate concentrations by 42% of baseline values 8 h after admission, normalized arterial pH from a mean(s.d.) of 7.367(0.063) to 7.39(0.1), and decreased the calculated base deficit from 9.2(7.3) mEq 1-1 to 6.4(10.4) mEq 1-1. In control patients lactate concentrations fell by approximately 14% of baseline concentrations (P < 0.02 compared with DCA recipients). Venous lactate concentrations fell a further 16% from baseline values after the second dose of DCA but this change was not significantly different from controls. There was no electrocardiographic or other evidence of toxicity associated with DCA. 5 These data suggest that a single intravenous infusion of DCA rapidly reduces hyperlactataemia in patients severely ill with malaria, and that DCA should be evaluated further as an adjunct to conventional antimalarial and supportive measures for such patients with lactic acidosis.
spellingShingle Krishna, S
Supanaranond, W
Pukrittayakamee, S
Kuile, F
Ruprah, M
White, N
The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title_full The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title_fullStr The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title_full_unstemmed The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title_short The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria.
title_sort disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria
work_keys_str_mv AT krishnas thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT supanaranondw thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT pukrittayakamees thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT kuilef thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT ruprahm thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT whiten thedispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT krishnas dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT supanaranondw dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT pukrittayakamees dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT kuilef dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT ruprahm dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria
AT whiten dispositionandeffectsoftwodosesofdichloroacetateinadultswithseverefalciparummalaria